Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: Possible link with the reduction in chondrocyte apoptosis and caspase 3 level

Arthritis and Rheumatism

Volumn 43, Issue 6, 2000, Pages 1290-1299

  Pelletier, Jean Pierre ^a   Jovanovic, Dragan V ^a   Lascau Coman, Viorica ^a   Fernandes, Julio C ^a   Manning, Pamela T ^b   Connor, Jane R ^b   Currie, Mark G ^b   Martel Pelletier, Johanne ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; N IMINOETHYLLYSINE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PLACEBO; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; DOG; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CARTILAGE, ARTICULAR; CASPASE 3; CASPASES; DISEASE PROGRESSION; DOGS; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; LYSINE; MATRIX METALLOPROTEINASES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OSTEOARTHRITIS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0034125854     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200006)43:6<1290::AID-ANR11>3.0.CO;2-R     Document Type: Article

References (44)

1. Pelletier JP, Martel-Pelletier J, Howell DS. Etiopathogenesis of osteoarthritis. In: Koopman WJ, editor. Arthritis & allied conditions: a textbook of rheumatology. 14th ed. Baltimore: Williams & Wilkins. In press.
2. Nuki G. Role of mechanical factors in the actiology, pathogenesis and progression of osteoarthritis. In: Reginster JY, Pelletier J-P, Martel-Pelletier J, Henrotin Y, editors. Osteoarthritis: clinical and experimental aspects. Berlin: Springer-Verlag; 1999. p. 101-14.
3. Ghosh P. Role of biomechanical factors. In: Reginster JY, Pelletier J-P, Martel-Pelletier J, Henrotin Y, editors. Osteoarthritis: clinical and experimental aspects. Berlin: Springer-Verlag; 1999. p. 115-33.
4. Williams CJ, Jimenez SA. Genetic and metabolic aspects. In: Reginster JY, Pelletier J-P, Martel-Pelletier J, Henrotin Y, editors. Osteoarthritis: clinical and experimental aspects. Berlin: Springer-Verlag; 1999. p. 134-55.
5. Martel-Pelletier J, Di Battista JA, Lajeunesse D. Biochemical factors in joint articular tissue degradation in osteoarthritis. In: Reginster JY, Pelletier J-P, Martel-Pelletier J, Henrotin Y, editors. Osteoarthritis: clinical and experimental aspects. Berlin: Springer-Verlag; 1999. p. 156-87.
6. Van den Berg WB, van der Kraan PM, van Beuningen HM. Role of growth factors and cartilage repair. In: Reginster JY, Pelletier J-P, Martel-Pelletier J, Henrotin Y, editors. Osleoarthritis: clinical and experimental aspects. Berlin: Springer-Verlag; 1999. p. 188-209.
7. McCarthy GM. Role of crystal deposition in the osteoarthritic joint. In: Reginster JY, Pelletier J-P, Martel-Pelletier J, Henrotin Y, editors. Osteoarthritis: clinical and experimental aspects. Berlin: Springer-Verlag; 1999. p. 210-27.
8. Evans CH, Stefanovic-Racic M, Lancaster J. Nitric oxide and its role in orthopaedic disease. Clin Orthop 1995;312:275-94.
9. Pelletier J-P, Jovanovic D. Fernandes JC, Manning P, Connor JR, Currie MG, et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 1998;41:1275-86.
10. Pelletier J-P, Jovanovic D, Fernandes JC, Manning PT, Connor JR, Currie MG, et al. Reduction in the structural changes of experimental osteoarthritis by a nitric oxide inhibitor. Osteoarthritis Cartilage 1999;7:416-8.
11. Pelletier J-P, Di Battista JA, Roughley PJ, McCollum R, Martel-Pelletier J. Cytokines and inflammation in cartilage degradation. In: Moskowitz RW, editor. Osteoarthritis: rheumatic disease clinics of North America. Philadelphia: WB Saunders; 1993. p. 545-68.
12. Pelletier J-P, Martel-Pelletier J, Altman RD, Ghandur-Mnaymneh L, Howell DS, Wocssner JF Jr. Collagenolytic activity and collagen matrix breakdown of the articular cartilage in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum 1983;26:866-74.
13. Blanco FJ, Guitian R, Vázquez-Martul E, de Toro FJ, Galdo F. Osteoarthritis chondrocytes die by apoptosis: a possible pathway for osteoarthritis pathology. Arthritis Rheum 1998;41:284-9.
14. Horton WE Jr, Feng L, Adams C. Chondrocyte apoptosis in development, aging and disease. Matrix Biol 1998;17:107-15.
15. Vaishnaw AK, McNally JD, Elkon KB. Apoptosis in the rheumatic diseases. Arthritis Rheum 1997;40:1917-27.
16. Nagata S. Apoptosis by death factor. Cell 1997;88:355-65.
17. Thornberry N, Lazebnik YA. Caspases: enemies within. Science 1998;281:1312-6.
18. Swanton E, Savory P, Cosulich S, Clarke P, Woodman P. Bcl-2 regulates a caspase-3/caspase-2 apoptotic cascade in cytosolic extracts. Oncogene 1999;18:1781-7.
19. Okuno S, Shimizu S, Ito T, Nomura M, Hamada E, Tsujimoto Y, et al. Bcl-2 prevents caspase-independent cell death. J Biol Chem 1998;273:34272-7.
20. Hashimoto S, Takahashi K, Amiel D, Coutts RD, Lotz M. Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum 1998;41:1266-74.
21. Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995;146:75-85.
22. Pelletier J-P, Di Battista JA, Raynauld JP, Wilhelm S, Martel-Pelletier J. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1 and oncogene protein synthesis in experimental osteoarthritis. Lab Invest 1995;72:578-86.
23. Pelletier J-P, Mineau F, Raynauld J-P, Woessner JF Jr, Gunja-Smith Z, Martel-Pelletier J. Intraarticular injections with methyl-prednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis. Arthritis Rheum 1994;37:414-23.
24. Fernandes JC, Martel-Pelletier J, Otterness IG, Lopez-Anaya A, Mineau F, Tardif G, et al. Effects of tenidap on canine experimental osteoarthritis. I. Morphologic and metalloprotease analysis. Arthritis Rheum 1995;38:1290-303.
25. Connor JA, Manning PT, Settle SL, Moore WM, Jerome GM, Webber RK, et al. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur J Pharmacol 1995;273:15-24.
26. Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971;53:523-37.
27. Chavira R Jr, Burnett TJ, Hageman JH. Assaying proteinases with azocoll. Anal Biochem 1984;136:446-50.
28. Moldovan F, Pelletier J-P, Hambor J, Cloutier J-M, Martel-Pelletier J. Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor β. Arthritis Rheum 1997;40:1653-61.
29. Smith GN Jr, Yu LP Jr, Brandt KD, Capello WN. Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage. J Rheumatol 1998: 25:532-5.
30. Cawston TE, Bigg HF, Clark IM, Hazleman BL. Identification of tissue inhibitor of metalloproteinase-2 (TIMP-2)-progelatinase complex as the third metalloproteinase inhibitor peak in rheumatoid synovial fluid. Ann Rheum Dis 1993;52:177-81.
31. Yu LP Jr, Smith GN Jr, Brandt KD, Myers SL, O'Connor BL, Brandt DA. Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum 1992;35:1150-9.
32. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: implications for atherosclerotic plaque stability. J Clin Invest 1996;98:2572-9.
33. Murrell GAC, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995;206:15-21.
34. Pelletier J-P, Lascau-Coman V, Jovanovic D, Fernandes JC, Manning P, Currie MG, et al. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. J Rheumatol 1999;26:2002-14.
35. Melchiorri C, Meliconi R, Frizziero L, Silvestri T, Pulsatelli L, Mazzetti I, et al. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum 1998;41:2165-74.
36. Pelletier JP, Mineau F, Ranger P, Tardif G, Martel-Pelletier J. The increased synthesis of inducible nitric oxide inhibits IL-1Ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage 1996;4:77-84.
37. Amin AR, Di Cesare PE, Vyas P, Attur MG, Tzeng E, Billiar TR, et al. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for an inducible "neuronal-like" nitric oxide synthase. J Exp Med 1995;182: 2097-102.
38. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci U S A 1992;89:3030-4.
39. Lin KT, Xue JY, Nomen M, Spur B, Wong PY. Peroxynitrite-induced apoptosis in HL-60 cells. J Biol Chem 1995;270:16487-90.
40. Dobashi K, Pahan K, Chahal A, Singh I. Modulation of endogenous antioxidant enzymes by nitric oxide in rat C6 glial cells. J Neurochem 1997;68:1896-903.
41. Asahi M, Fujii J, Suzuki K, Seo HG, Kuzuya T, Hori M, et al. Inactivation of glutathione peroxidase by nitric oxide: implication for cytotoxicity. J Biol Chem 1995:270:21035-9.
42. Ushmorov A, Ratter F, Lehmann V. Droge W, Schirrmacher V, Umansky V. Nitric-oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome C release. Blood 1999l93:2342-52.
43. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479-89.
44. Erlacher L, Maier R, Ullrich R, Kiener H, Aringer M, Menschik M, et al. Differential expression of the protooncogene bcl-2 in normal and osteoarthritic human articular cartilage. J Rheumatol 1995;22:926-31.